A qualitative investigation of the Montgomery-Åsberg depression rating scale: discrepancies in rater perceptions and data trends in remote assessments of rapid-acting antidepressants in treatment resistant depression.
Frontiers in Psychiatry 2024 Gianna Capodilupo, Raymond Blattner, Anita Must et al. 3 citations
Despite the development of many successful pharmaceutical interventions, a significant subset of patients experience treatment-resistant depression (TRD). Ketamine and its derivatives constitute a novel therapeutic approach to treat TRD; however, standard tools, such as the Montgomery-Åsberg Depression Rating Scale (MADRS) are still being used to measure symptoms and track changes. The aim of...
DOI: 10.3389/fpsyt.2024.1289630 (opens in new tab)
Full text (opens in new tab)
Rapid acting antidepressants
Rater perception
Depression treatment
Clinical assessment scales
+3